CRT 2017 late-breaking trials.

1. Impact of technique on early and late outcomes following coronary Bioresorbable scaffold implantation: Analysis from the ABSORB trials . . . . . 304 2. Two-year clinical outcomes of the ABSORB BVS compared EES: A propensity matched analysis of the BVS expand registry . . . . . . . . . . . . 305 3. Transcatheter aortic valve replacement using the Lotus valve with Depth Guard: First report from the RESPOND Extension study . . . . . . . . . 305 4. Polymer-free biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 12 Month clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305 5. RAdial Same-Day DischArge after PCI: The RASADDA-PCI trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306 6. New Drug-eluting stents in patients with Diabetes mellitus and multi-vessel Disease (3D Registry) . . . . . . . . . . . . . . . . . . . . . . . 306 7. Lutonix paclitaxel-coated balloon to treat obstructive lesions in the superficial femoral and popliteal arteries. Preliminary six-month results from the SAFE-DCB study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306 8. Treatment of severely calcified coronary lesions with the coronary orbital atherectomy system Micro Crown: 1-year results from the COAST trial . . 307 9. Impact of calcification on percutaneous coronary intervention outcomes: Insights from the MACE study . . . . . . . . . . . . . . . . . . . . 307